Effect Ashang and Persian Medicine dietary modification with Mefenamic acid on menorrhagia

Study of effect herbal product Ashang (myrtus+ plantago) and Persian Medicine dietary modification with Mefenamic acid on menorrhagia :A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221212056789N1

Enrollment

120

Registered

2023-03-12

Start date

2024-04-26

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excessive and frequent menstruation with regular cycle. Excessive and frequent menstruation with regular cycle

Interventions

Intervention 1: The first intervention group: receiving 1 capsules of 250 mg mefenamic acid after each meal. Intervention 2: Intervention group2: Take1 Ashang150 mg capsules after every meal(Ashang ca

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Unmarried women, 18-50 years old Regular menstrual cycle Suffering from menorrhagia based on PBAC criteria Patient satisfaction Hemoglobin more than 10

Exclusion criteria

Exclusion criteria: Severe uterine bleeding that requires surgical interventions Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Primary outcome: Higham questionnaire score (PBAC)(Pictorial Blood loss Assessment Chart). Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study period, i.e. after 3 cycles of treatment with Ashang. Method of measurement: Higham Questionnaire (PBAC).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSabikeh Salehi

Gorgan University of Medical Sciences

sabikeh.salehi@gmail.com+98 17 3254 7189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026